- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Urinary Bladder, Neurogenic in New Zealand
Total 8323 results
-
Weill Medical College of Cornell UniversityCompletedOveractive BladderUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; New York Presbyterian HospitalTerminatedBladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAmgenTerminated
-
University of RochesterAstellas Pharma IncTerminated
-
Columbia UniversityCompletedBladder Cancer | ComplicationsUnited States
-
Asieris Pharmaceuticals (AUS) Pty Ltd.Completed
-
Edward MessingImagin MedicalCompleted
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
GlaxoSmithKlineCompletedOveractive BladderAustralia
-
University of RochesterCompletedOveractive BladderUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | High Risk SuperficialUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder CancerUnited States
-
Columbia UniversityCelgene CorporationUnknownBladder CancerUnited States
-
Icahn School of Medicine at Mount SinaiCompleted
-
PfizerCompletedOveractive Bladder (OAB) With Symptoms of Frequency, Urgency, and UrgencyUnited States
-
Matthew GalskyNovartisTerminatedBladder Cancer | Solid TumorsUnited States
-
Urovant Sciences GmbHIon Channel InnovationsCompletedOveractive BladderUnited States
-
AllerganCompletedOveractive BladderPoland, United Kingdom, Portugal, South Africa, Ukraine, Australia, Netherlands, Canada, Singapore, Russian Federation, Germany, Brazil, Austria, Slovakia, Czechia, United States, Taiwan, Italy, France, Belgium, Spain, New Zealand
-
Yale UniversityBayerCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZenecaCompletedAdenocarcinoma of the Bladder | Squamous Cell Carcinoma of the Bladder | Metastatic Bladder Cancer | Non-Transitional Cell Carcinoma of the Urothelial Tract | Small Cell of the BladderUnited States
-
Asieris Pharmaceutical Technologies Co., Ltd.CompletedNon-Muscle Invasive Bladder Cancer (NMIBC)United States
-
State University of New York at BuffaloAstellas Pharma IncWithdrawnUrinary Frequency/Urgency | Bladder Pain Syndrome | Bladder IrritableUnited States
-
PfizerCompletedOveractive Bladder With Symptoms of Frequency, Urgency, and Urge Urinary IncontinenceUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
Memorial Sloan Kettering Cancer CenterNew York University; University of North Carolina, Chapel HillCompletedBladder CancerUnited States
-
Far Eastern Memorial HospitalNational Science Council, TaiwanCompletedOveractive Bladder Syndrome | Lower Urinary Tract DysfunctionTaiwan
-
Aadi Bioscience, Inc.National Cancer Institute (NCI)CompletedNon-muscle Invasive Bladder Cancer (NMIBC)United States
-
Icahn School of Medicine at Mount SinaiCompletedOveractive Bladder | Pelvic Organ ProlapseUnited States
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Columbia UniversityTerminatedGall Bladder DiseaseUnited States
-
Halozyme TherapeuticsCompletedSuperficial Bladder CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedOveractive Bladder (OAB)United States, Canada
-
National Cancer Institute (NCI)CompletedStage III Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
MedtronicNeuroCompletedOveractive BladderUnited States
-
University of KentuckyBayerTerminated
-
PfizerWithdrawnBladder CancerPoland, United States
-
Atlantic Health SystemCompletedOveractive Bladder | Urinary Incontinence | Voiding DisordersUnited States
-
Astellas Pharma Europe B.V.CompletedOveractive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic DiseasesBelgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
-
GlaxoSmithKlineCompletedOveractive BladderGermany, Taiwan, Netherlands, Spain, Australia, Korea, Republic of, Latvia, Argentina, Slovenia, Finland, France, South Africa, Poland, New Zealand
-
University of RochesterTerminatedOveractive Bladder | Urge IncontinenceUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Completed
-
Advanced Tactile Imaging, Inc.Princeton UrogynecologyCompleted
-
Velicept Therapeutics, Inc.CompletedOveractive BladderUnited States
-
Endo PharmaceuticalsTerminated
-
Far Eastern Memorial HospitalRecruitingOveractive Bladder SyndromeTaiwan
-
Memorial Sloan Kettering Cancer CenterCompletedBladder Cancer | Urinary Cancer | Nonmuscle Invasive Bladder CancerUnited States
-
Taris Biomedical LLCCompletedIdiopathic Overactive Bladder With Urinary IncontinenceUnited States